Effect of high-dose statin versus low-dose statin plus ezetimibe on endothelial function: a meta-analysis of randomized trials. (Q38019682)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

meta-analysis

0 references

title

Effect of high-dose statin versus low-dose statin plus ezetimibe on endothelial function: a meta-analysis of randomized trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Xiliang Zhao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Shuyang Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Guangyao Zhai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Lilin Guo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Zhuang Tian

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

18 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cardiovascular Pharmacology and Therapeutics

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

357-365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Ezetimibe therapy and its influence on oxidative stress and fibrinolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Simvastatin with or without ezetimibe in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Role of endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Endothelial function: cardiac events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: comparative study between simvastatin and simvastatin/ezetimibe coadministration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412449384

21 January 2018

Identifiers

DOI

10.1177/1074248412449384

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710021%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference